Professional Survey

Section 1 of 10

Your Professional Background

We start with your role and clinical context — this helps us accurately interpret your responses across the full dataset.

Q1. What is your primary professional role?

Q2. How many years have you worked in respiratory or related care?

Q3. What is your primary care setting?

Hospital — inpatient / acute care Hospital — outpatient / clinic Primary care practice Home healthcare / community Pulmonary rehabilitation Long-term care / skilled nursing facility Telehealth / remote care Mixed / multiple settings

Q4. Which respiratory conditions do you most commonly manage? (Select all that apply)

COPD / emphysema / chronic bronchitis Asthma Interstitial lung disease / pulmonary fibrosis Obstructive sleep apnea Cystic fibrosis / bronchiectasis Pulmonary arterial hypertension Post-COVID respiratory conditions Mixed / general respiratory

Section 2 of 10

Patient Education Gaps

Most respiratory admissions involve a patient education failure somewhere in the chain. Tell us where you see it.

Q5. How would you rate the overall quality of respiratory patient education in your setting?

Very poorExcellent

Q6. Which areas of patient education are most commonly inadequate? (Select all that apply)

Q7. What is the most significant barrier to delivering effective patient education in your setting?

Section 3 of 10

Adherence Barriers

Non-adherence drives enormous avoidable harm. Help us understand what you see on the frontline.

How often is non-adherence caused by…	Rarely	Sometimes	Often	Almost Always
Cost / unaffordability of medications
Patient doesn't understand why medication is needed
Complexity — too many medications / devices
Side effects (real or perceived)
Low health literacy / language barriers
Mental health (depression, anxiety, hopelessness)
Social isolation / lack of caregiver support

Q15. What is the single most common adherence failure you see — and why does the system fail to address it?

Section 4 of 10

Discharge & Transitions of Care

Discharge is where respiratory patients are most at risk. Tell us where the handoff breaks down.

Q16. How would you rate the quality of respiratory discharge planning in your primary setting?

Very poorExcellent

Q17. Which discharge failures do you witness most frequently? (Select all that apply)

No outpatient follow-up booked before discharge Home equipment not in place at discharge Discharge prescriptions incorrect or incomplete Patient unclear on what to do at home No written exacerbation action plan provided Poor communication between inpatient and community teams Preventable readmission within 30 days Caregiver not briefed or included in planning

Q18. What percentage of your respiratory patients do you estimate are readmitted within 90 days of discharge?

Q19. What one change would most reduce preventable respiratory readmissions?

Section 5 of 10

Oxygen Therapy & Non-Invasive Ventilation

Oxygen and NIV are central to respiratory management — and among the most frequently misapplied interventions. Tell us what you see in practice.

Q20. How frequently do you encounter patients whose long-term oxygen therapy (LTOT) was initiated without a qualifying arterial blood gas or formal oximetry assessment?

Rarely — formal assessment is standard in my setting Sometimes — occasionally bypassed under pressure Often — assessment is inconsistent Regularly — it's a systemic gap in my setting Not applicable to my role or setting

Q21. Which oxygen therapy prescribing or management issues do you most commonly encounter? (Select all that apply)

Oxygen initiated without qualifying ABG or oximetry Incorrect flow rate — set too low or too high Patients not titrated during ambulation or exertion Nocturnal hypoxemia not assessed or addressed Patients self-adjusting flow without clinical guidance Equipment delivery delays preventing timely initiation Patient non-compliance due to social stigma or equipment burden Patients on LTOT not reassessed for continued need Inadequate attention to hypercapnia risk in COPD patients

Q22. How would you rate the overall quality of NIV (BiPAP / CPAP / AVAPS) initiation and follow-up in your primary setting?

Very poorExcellent

Q23. Which NIV-related barriers do you most commonly encounter in your patients? (Select all that apply)

Inadequate initial titration or pressure settings Poor mask fit causing discomfort, leaks, or abandonment Insufficient patient education on device use and troubleshooting No structured review of compliance data (e.g. CPAP download data) Insurance restrictions limiting appropriate NIV access Patient claustrophobia or anxiety preventing consistent use Inadequate DME support for device troubleshooting in the home Suboptimal ventilator settings for COPD with hypercapnia or OHS No scheduled follow-up after NIV initiation

Q24. What single change would most improve oxygen therapy or NIV outcomes for your patients?

Section 6 of 10

Pulmonary Rehabilitation

Pulmonary rehab is one of the most evidence-based interventions in respiratory care — and one of the most underutilized. Tell us what's happening in your setting.

Q25. What percentage of your clinically eligible patients are referred to a formal pulmonary rehabilitation program?

Q26. What are the primary barriers to pulmonary rehab access or program completion in your patient population? (Select all that apply)

Q27. How would you rate the integration of pulmonary rehabilitation into the standard respiratory care pathway in your setting?

Not integrated at allFully integrated

Q28. What intervention — clinical, structural, or policy — would most increase pulmonary rehab uptake and program completion in your population?

Section 7 of 10

Follow-Up & Continuity of Care

Consistent follow-up is the difference between managed disease and repeated crisis. Tell us where continuity breaks down in your setting.

In your setting, how often do these follow-up failures occur?	Rarely	Sometimes	Often	Almost Always
Patients miss scheduled follow-up appointments
Follow-up interval is too long to detect early deterioration
Clinical records are not shared across care settings
Patients do not know when to escalate worsening symptoms
No single clinician or coordinator owns the patient's care journey
Post-discharge medication reconciliation is incomplete or missed

Q35. What follow-up intervention — technology, process, or staffing model — would have the highest impact on reducing preventable deterioration?

Section 8 of 10

Systemic Gaps & Workforce

Beyond your immediate clinical setting — where is the system itself failing respiratory patients and the professionals who care for them?

Q36. Which systemic gaps do you believe are most damaging to respiratory patient outcomes? (Select up to 3)

Q37. How adequate is the respiratory therapy and pulmonary specialist workforce supply in the area where you practice?

Adequate — staffing is sufficient for patient volume Somewhat inadequate — we manage, but it's stretched Significantly inadequate — patient care is directly affected Critical shortage — a serious and ongoing patient safety concern

Q38. How often do patient-reported experiences actually influence clinical protocols or policy decisions in your experience?

Never — patient experience data rarely reaches decision-makers Rarely — occasional surveys with no visible follow-through Sometimes — depends heavily on the institution Often — patient voice is meaningfully integrated in my setting

Section 9 of 10

Professional Wellbeing & Workflow

Clinician wellbeing directly affects patient safety. We ask because it matters — and because the data informs what Nevidra advocates for in workforce policy.

Q39. How would you rate your current level of professional burnout?

No burnoutSevere burnout

Q40. Which factors most contribute to burnout or job dissatisfaction in your respiratory care setting? (Select all that apply)

Chronic understaffing and unsustainable patient-to-clinician ratios Excessive EHR documentation burden Watching patients deteriorate due to systemic failures outside your control Feeling that clinical input does not meaningfully influence outcomes Moral distress — providing care you know is suboptimal given systemic constraints Administrative and prior authorization processes consuming clinical time Inadequate compensation relative to scope of practice and complexity

Q41. Which clinical workflow challenges consume the most non-clinical time in your working week? (Select all that apply)

Prior authorization and insurance documentation EHR documentation and charting beyond what is clinically meaningful Chasing referrals, equipment orders, or DME authorizations Coordinating care across fragmented interdisciplinary teams Patient outreach, follow-up scheduling, and no-show management Translating clinical guidelines into patient-accessible language Insurance appeals and coverage dispute resolution

Q42. Do you feel the healthcare system adequately supports your ability to deliver high-quality respiratory care?

Yes — I have the tools, time, and support I need Mostly — significant gaps exist but I can work around them Rarely — systemic barriers consistently undermine my clinical work No — the system actively makes it harder to care for patients well

Section 10 of 10

Research Partnership & Final Thoughts

You're nearly done. This final section captures your view on the research infrastructure needed to drive real change — and invites your continued involvement.

Q43. What single change — in policy, technology, clinical education, or system design — would most improve outcomes for your respiratory patients?

Q44. How valuable would a centralised, longitudinal patient-reported outcomes (PRO) database — capturing real-world symptom burden, functional status, and treatment experience across respiratory conditions — be to your clinical practice or research?

Extremely valuable — I'd actively use it to inform clinical decisions Valuable — would strengthen my understanding of patient experience Somewhat — value depends on data quality and methodology Not particularly useful for my current practice

Q45. What would need to be true about such a system for you to trust and act on the data? (Select all that apply)

Use of validated clinical instruments (CAT, mMRC, PHQ, EQ-5D, PROMIS) IRB-approved research protocol with ethical oversight Findings subjected to peer review before clinical application Diverse and representative patient sample across demographics and settings Longitudinal design — not just cross-sectional snapshots Co-developed with clinicians across respiratory specialties Open-access data — not paywalled or proprietary Rigorously de-identified to protect patient privacy

Q46. Is there anything else you'd like Nevidra's research team to know — a clinical reality, a gap, or an opportunity we haven't asked about?

Q47. Would you be willing to join Nevidra's Professional Advisory Network — receiving de-identified findings, contributing to research design, and connecting with peers working on these problems?

Yes — I'd like to be actively involved Maybe — please send me more information first No, but thank you for asking

Your Clinical Voice
Changes Patient Care

Your Professional Background

Patient Education Gaps

Adherence Barriers

Discharge & Transitions of Care

Oxygen Therapy & Non-Invasive Ventilation

Pulmonary Rehabilitation

Follow-Up & Continuity of Care

Systemic Gaps & Workforce

Professional Wellbeing & Workflow

Research Partnership & Final Thoughts

Thank you for your expertise.

Join the Nevidra Professional Advisory Network

No problem at all.

Your Clinical VoiceChanges Patient Care

Before You Begin — Informed Consent

Antes de Comenzar — Consentimiento Informado

Your Professional Background

Patient Education Gaps

Adherence Barriers

Discharge & Transitions of Care

Oxygen Therapy & Non-Invasive Ventilation

Pulmonary Rehabilitation

Follow-Up & Continuity of Care

Systemic Gaps & Workforce

Professional Wellbeing & Workflow

Research Partnership & Final Thoughts

Thank you for your expertise.

Join the Nevidra Professional Advisory Network

No problem at all.

Your Clinical Voice
Changes Patient Care